Trials / Conditions / Stage IIIC Fallopian Tube Cancer

Stage IIIC Fallopian Tube Cancer

20 registered clinical trials studyying Stage IIIC Fallopian Tube Cancer.

Status	Trial	Sponsor	Phase
Completed	Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovari NCT03188432	Wake Forest University Health Sciences	Phase 2
Withdrawn	PET Imaging of Ovarian Carcinoma With 18F-FSPG NCT02872519	Vanderbilt-Ingram Cancer Center	EARLY_Phase 1
Withdrawn	Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Perito NCT02833506	Roswell Park Cancer Institute	Phase 1
Terminated	IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, o NCT03029611	University of Washington	Phase 2
Withdrawn	Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian NCT02470559	Barbara Ann Karmanos Cancer Institute	Phase 1
Completed	Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritone NCT02122185	University of Chicago	Phase 2
Completed	Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavi NCT02111941	Mayo Clinic	EARLY_Phase 1
Withdrawn	Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or NCT01982487	Roswell Park Cancer Institute	Phase 1 / Phase 2
Completed	Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Pri NCT01536054	Roswell Park Cancer Institute	Phase 1
Completed	Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Pri NCT01606241	Mayo Clinic	Phase 1
Terminated	Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherap NCT01275664	Gynecologic Oncology Group	N/A
Completed	Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer NCT01764802	Ohio State University Comprehensive Cancer Center	Phase 2
Completed	OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Ca NCT00857545	Gynecologic Oncology Group	Phase 2
Completed	Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritone NCT01080521	Gynecologic Oncology Group	—
Completed	Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian NCT02311907	Alliance for Clinical Trials in Oncology	Phase 3
Completed	Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Isl NCT01010126	National Cancer Institute (NCI)	Phase 2
Terminated	YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal NCT00899093	Gynecologic Oncology Group	—
Completed	Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal NCT00388037	National Cancer Institute (NCI)	Phase 2
Completed	Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian NCT00262847	National Cancer Institute (NCI)	Phase 3
Completed	Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442	Gynecologic Oncology Group	—